IDEXX Laboratories is expected to release its fiscal fourth-quarter earnings soon, and analysts project a double-digit ...

Passive investing in index funds can generate returns that roughly match the overall market. But investors can ...

It notched a beat-and-raise third quarter. It cited innovation and increased customer take-up as reasons for the solid growth it posted during the frame. Idexx published its third-quarter figures well ...

IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 10 years by 11.91% on an annualized basis producing an average annual return of 25.31%. Currently, IDEXX Laboratories has a ...

IDEXX Laboratories, Inc. (IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market return. The last ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

IDEXX Laboratories continues to outperform the S&P 500, driven by strong recurring revenue and a robust customer ecosystem. IDXX delivered a double beat in Q3, with revenue up 13% and EPS up 21%, ...

Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) focuses on enhancing the health and well-being of pets, people, and livestock. It develops and distributes products and services for the ...

Achieves first quarter revenue growth of 4% as reported and 5% organic, supported by CAG Diagnostics recurring revenue growth of 3% as reported and 4.5% organic. Organic revenue growth supported by ...